Company

Enfusion, Inc.

Headquarters: Chicago, IL, United States

Employees: 1,102

CEO: Mr. Oleg Movchan

NYSE: ENFN -3.73%

Detailed Description

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Financials

Last Financial Reports Date Dec. 31, 2023
Revenue TTM $174.5 M
EBITDA $22.0 M
Gross Profit TTM $116.9 M
Profit Margin 3.45%
Operating Margin 4.59%
Quarterly Revenue Growth 14.70%
Financial Reports & Statistics

Stocks & Indices

Enfusion, Inc. has the following listings and related stock indices.


Stock: NYSE: ENFN wb_incandescent

Details

Headquarters:

125 South Clark Street

Chicago, IL 60603

United States

Phone: 312 253 9800